Development of target delivery system based on actinomycin class drugs and recombinant alpha-fetoprotein

Dokl Biochem Biophys. 2017 Mar;473(1):148-150. doi: 10.1134/S1607672917020156. Epub 2017 May 17.

Abstract

A recombinant alpha-fetoprotein (rAFP) was obtained in the yeast P. pastoris system, and its functional activity was confirmed. A method for producing polymer particles loaded with dactinomycin was developed, and a conjugate of these nanoparticles with rAFP was synthesized. The efficiency of the obtained conjugate on the HeLa, SKOV3, and MG-63 tumor cells and the absence of toxicity on the normal cells was shown. Experiments in vivo demonstrated a significant increase in the antitumor efficacy of the conjugate at a lower general toxicity as compared to the commercially available dactinomycin.

MeSH terms

  • Animals
  • Dactinomycin / chemistry*
  • Drug Carriers / chemistry*
  • HeLa Cells
  • Humans
  • Mice
  • Nanoparticles / chemistry
  • Recombinant Proteins / chemistry*
  • alpha-Fetoproteins / chemistry*

Substances

  • Drug Carriers
  • Recombinant Proteins
  • alpha-Fetoproteins
  • Dactinomycin